Sponsor:
The Cooper Health System
Code:
NCT03973957
Conditions
Pleural Effusion
Pleural Diseases
Malignant Pleural Effusion
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Indwelling pleural catheter placement
Fentanyl Citrate
Talc Slurry
Drainage collection bag
Brief summary:
Conditions
Pleural Effusion
Pleural Diseases
Malignant Pleural Effusion
Study ID
NCT03973957
Start date
May 27, 2019
Status verified date
Jun, 2019
Completion date
Jan 31, 2021
Anticipated
Primary completion date
Jan 31, 2021
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
124 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Control Arm
active comparator: Intervention Arm
Interventions
Indwelling pleural catheter placement
Fentanyl Citrate
Talc Slurry
Drainage collection bag
Primary outcome measure
Central contacts
Locations
Cooper University Hospital
Recruiting
Camden, New Jersey, United States, 08103
Contacts
Wissam Abouzgheib
856-342-2406Sponsor
The Cooper Health System
Last update posted
Jun 4, 2019
Last verified
Jun, 2019
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The Cooper Health System on 2019-06-04.